FacebookTwitterGoogle+RedditEmail

Born With a Statin Deficiency?

by MARTHA ROSENBERG

When Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, MA presented the results of the AstraZeneca-funded JUPITER study at the American Heart Association conference in November–JUPITER standing for The Justification for the Use of Statins in Primary Prevention–there were a lot more stenographers than skeptics in the press corps.

How could a drug company-funded study designed to show why the general population should use its drug (Crestor, or rosuvastatin) be objective? Or even newsworthy?

Especially when its lead author is co-inventor on the related patent?

And its authors list 131 financial ties to drug companies? Hello?

But the press didn’t let overt conflicts of interest–COIs as pharma calls them because they’re so common–ruin the story.

“AstraZeneca’s Crestor Cuts Death, Heart Attack,” exalted Reuters remembering the PR dictim of getting Name and Company in the headline. “Crestor Study Seen Changing Preventive Treatment!”

“Wider Cholesterol Drug Use May Save Lives,” trumpeted other headlines.

“Statins For Everyone!”

“Crestor In The Water?”

Was this the same Crestor which was vilified in a Lancet editorial three months after its 2003 US approval as “inadequately investigated”?

Named as one of the top five most dangerous drugs by the FDA’s Dr. David “Vioxx” Graham on Capitol Hill in 2004?

Petitioned for recall by the Washington D.C. based Public Citizen?

Found worthless against chronic heart failure just one month earlier in Lancet?

In the feeder frenzy to cover the self-engineered drug breakthrough, where was press mention of another American Heart Association finding about Crestor in its journal Circulation in 2005? [111:3051-3057]

That Crestor “was significantly more likely to be associated with the composite end point of rhabdomyolysis, proteinuria, nephropathy, or renal failure,” than other drugs?

Where was mention of the FDA warning about rhabdomyolysis–the muscle disease that did Bayer’s Baycol in–that was added to Crestor in 2005 after a patient death–along with warnings to the physician about Crestor use in Asian patients, people with severe kidney disease and patients taking cyclosporine?

Oops.

But while the gee whiz press focused on the JUPITER study’s startling results–the Crestor group had a 54 percent reduction in heart attacks, 48 percent reduction in strokes and 20 percent reduction in death compared to placebo–especially in light of the fact that the study group was free of heart disease and high cholesterol, most doctors wouldn’t drink the AstraZeneca Kool-Aid.

The study’s 17,802 enrollees may have had normal levels of the bad LDL cholesterol but some were “walking vasculopaths,” with abnormal C-reactive protein levels [CRP] which indicate inflammation in the body said Dr. Bernadine Healy, health editor for U.S. News & World Report.

“As a result, the JUPITER trial was riddled with obesity, high blood pressure, prediabetes, and genes predisposing to heart disease,” said Healy. “Almost 3,000 enrollees were smokers, a big time CRP elevator, and only 10 percent took aspirin, an inexpensive preventive medicine that protects against both heart disease and stroke. (Aspirin also lowers CRP.) Other study patients were really healthy, free of any known risk factors and yet had elevated CRP for no obvious reason.”

While the press bought AstraZeneca’s contrivance that the JUPITER study was so conclusive it was ended early, many of the 470 doctors who posted online comments after the study in the New England Journal of Medicine (Nov. 20, 2008) said you ended the trial WHEN?

“It is well established that RCTs [randomized controlled trials] stopped early overestimate benefits significantly,” wrote a physician from Rochester, MN.

“It is shocking that this trial was terminated 50% through, based on a small absolute benefit, with real questions about long term risk,” said a poster from the Public Health Law Program, LSU Law Center.

“There is no justification for stopping the follow-up, even if the triallists felt it was unethical to recruit new patients,” wrote a physician from Yorkshire, UK. “Congratulations to AstraZeneca for selling the results to the uncritical lay media. I feel sorry for all the family doctors who will be pestered by patients for some time to come.”

Doctors also balked at the study’s ipso facto preference for a pill over lifestyle changes like diet and exercise–including the well known Dr. Dean Ornish of Preventive Medicine Research Institute who noted the nation spent $20 billion on cholesterol-lowering drugs last year.

While cardiologists were soft on the study–except one who assailed the Western “pandemic food addiction and the mirage of immortality in a bottle of pills”–many other doctors detected disease mongering behind JUPITER of the sort that sold HRT and Vioxx to anyone over 50.

Even a medical student wasn’t impressed.

“I don’t think risking the patient’s life by giving him statins is a correct procedure. I would be giving him/her benefits for a disease which has not been diagnosed yet and increasing the odds of developing another disease (Diabetes),” she wrote.

MARTHA ROSENBERG is staff cartoonist on the Evanston Roundtable. She can be reached at mrosenberg@evmark.org

 

 

 

 

 

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

More articles by:

CounterPunch Magazine

minimag-edit

bernie-the-sandernistas-cover-344x550

zen economics

February 20, 2017
Bruce E. Levine
Humiliation Porn: Trump’s Gift to His Faithful…and Now the Blowback
Melvin Goodman
“Wag the Dog,” Revisited
Robert Hunziker
Fukushima: a Lurking Global Catastrophe?
David Smith-Ferri
Resistance and Resolve in Russia: Memorial HRC
Kenneth Surin
Global India?
Norman Pollack
Fascistization Crashing Down: Driving the Cleaver into Social Welfare
Patrick Cockburn
Trump v. the Media: a Fight to the Death
Susan Babbitt
Shooting Arrows at Heaven: Why is There Debate About Battle Imagery in Health?
Matt Peppe
New York Times Openly Promotes Formal Apartheid Regime By Israel
David Swanson
Understanding Robert E. Lee Supporters
Michael Brenner
The Narcissism of Donald Trump
Martin Billheimer
Capital of Pain
Thomas Knapp
Florida’s Shenanigans Make a Great Case for (Re-)Separation of Ballot and State
Jordan Flaherty
Best Films of 2016: Black Excellence Versus White Mediocrity
Weekend Edition
February 17, 2017
Friday - Sunday
David Price
Rogue Elephant Rising: The CIA as Kingslayer
Matthew Stevenson
Is Trump the Worst President Ever?
Jeffrey St. Clair
Roaming Charges: Tinker, Tailor, Soldier, Flynn?
John Wight
Brexit and Trump: Why Right is Not the New Left
Diana Johnstone
France: Another Ghastly Presidential Election Campaign; the Deep State Rises to the Surface
Neve Gordon
Trump’s One-State Option
Roger Harris
Emperor Trump Has No Clothes: Time to Organize!
Joan Roelofs
What Else is Wrong with Globalization
Andrew Levine
Why Trump’s Muslim Travel Ban?
Mike Whitney
Blood in the Water: the Trump Revolution Ends in a Whimper
Vijay Prashad
Trump, Turmoil and Resistance
Ron Jacobs
U.S. Imperial War Personified
David Swanson
Can the Climate Survive Adherence to War and Partisanship?
Andre Vltchek
Governor of Jakarta: Get Re-elected or Die!
Patrick Cockburn
The Coming Destruction of Mosul
Norman Pollack
Self-Devouring Reaction: Governmental Impasse
Steve Horn
What Do a Louisiana Pipeline Explosion and Dakota Access Pipeline Have in Common? Phillips 66
Brian Saady
Why Corporations are Too Big to Jail in the Drug War
Graham Peebles
Ethiopia: Peaceful Protest to Armed Uprising
Luke Meyer
The Case of Tony: Inside a Lifer Hearing
Binoy Kampmark
Adolf, The Donald and History
Robert Koehler
The Great American Awakening
Murray Dobbin
Canadians at Odds With Their Government on Israel
Fariborz Saremi
A Whole New World?
Joyce Nelson
Japan’s Abe, Trump & Illegal Leaks
Christopher Brauchli
Trump 1, Tillerson 0
Yves Engler
Is This Hate Speech?
Dan Bacher
Trump Administration Exempts Three CA Oil Fields From Water Protection Rule at Jerry Brown’s Request
Richard Klin
Solid Gold
Melissa Garriga
Anti-Abortion and Anti-Fascist Movements: More in Common Than Meets the Eye
Thomas Knapp
The Absurd Consequences of a “Right to Privacy”
FacebookTwitterGoogle+RedditEmail